The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 502.00
Bid: 500.00
Ask: 502.00
Change: 7.00 (1.41%)
Spread: 2.00 (0.40%)
Open: 492.00
High: 502.00
Low: 492.00
Prev. Close: 495.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

21 Nov 2016 08:36

RNS Number : 6900P
Liberum Capital Limited
21 November 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Creston PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected party to the offeree

(d) Date dealing undertaken:

 18th November 2016

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

 

Ordinary 10P

 

 

Purchase

 

 

27647

 

 

 

 

1.2385GBP

 

 

1.2325GBP

 

 

Ordinary 10P

 

 

 

Sale

 

 

 

 

27647

 

 

1.2385GBP

 

 

1.2325GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

 21st November 2016

Contact name:

Harriet Blackie

Telephone number:

020 3100 2012

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERGIBDBSXDBGLB
Date   Source Headline
15th Dec 201012:40 pmRNSResult of Meeting
30th Nov 20107:00 amRNSInterim Results
30th Nov 20107:00 amRNSAcquisition
8th Nov 20102:18 pmRNSHolding(s) in Company
19th Oct 20101:09 pmRNSHolding(s) in Company
19th Oct 20101:07 pmRNSHolding(s) in Company
11th Oct 201011:12 amRNSNotice of Interim Results
28th Sep 20108:00 amRNSCreation of E-Healthcare Start-Up
2nd Sep 201010:55 amRNSAGM Statement
26th Jul 20107:00 amRNSInterim Management Statement
14th Jul 20104:12 pmRNSDirector/PDMR Shareholding
14th Jul 201011:54 amRNSDisposal
13th Jul 20109:51 amRNSResult of General Meeting
28th Jun 20104:30 pmRNSPosting of Circular
28th Jun 201010:35 amRNSHolding(s) in Company
28th Jun 20107:01 amRNSDisposal
28th Jun 20107:00 amRNSFinal Results
26th May 20104:52 pmRNSHolding(s) in Company
26th May 20108:40 amRNSNotice of Results
21st May 201012:56 pmRNSHolding(s) in Company
13th May 20105:46 pmRNSHolding(s) in Company
26th Apr 20102:13 pmRNSHolding(s) in Company
22nd Apr 20103:05 pmRNSHolding(s) in Company
20th Apr 20107:00 amRNSPre-Close Trading Statement
6th Apr 20104:29 pmRNSDirector/PDMR Shareholding
6th Apr 20104:26 pmRNSDirector/PDMR Shareholding
23rd Mar 20104:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20104:41 pmRNSDirector/PDMR Shareholding
17th Feb 20105:51 pmRNSHolding(s) in Company
3rd Feb 20107:00 amRNSInterim Management Statement
10th Dec 20097:33 amRNSDirector/PDMR Shareholding
2nd Dec 20097:00 amRNSDirector/PDMR Shareholding
30th Nov 20097:00 amRNSHalf Yearly Report
26th Nov 200910:31 amRNSDirector Declaration
26th Nov 20097:00 amRNSDirectorate Change
12th Oct 200910:46 amRNSNotice of Results
8th Sep 200912:40 pmRNSDirector/PDMR Shareholding
8th Sep 200912:29 pmRNSDirector/PDMR Shareholding
8th Sep 200912:27 pmRNSIssue of Shares under Long Term Incentive Plan
2nd Sep 20094:17 pmRNSResult of AGM
25th Aug 20094:48 pmRNSHolding(s) in Company
14th Aug 20097:00 amRNSInterim Management Statement
17th Jul 20093:13 pmRNSHolding(s) in Company
10th Jul 20094:54 pmRNSHolding(s) in Company
8th Jul 200912:15 pmRNSDirector/PDMR Shareholding
8th Jul 200912:08 pmRNSDirector/PDMR Shareholding
7th Jul 20097:00 amRNSCreston PLC Placing
26th Jun 200912:09 pmRNSDirector/PDMR Shareholding
25th Jun 20095:48 pmRNSDirector/PDMR Shareholding
23rd Jun 20097:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.